Holen Sie sich die Stockscreener-App
209.41
0.47%
-0.98
Handel nachbörslich:
210.00
0.59
+0.28%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
Here's How Neuroscience Drugs Boost AbbVie's Q1 Sales Growth - TradingView
TD Private Client Wealth LLC Sells 9,822 Shares of AbbVie Inc. $ABBV - MarketBeat
Mission Wealth Management LP Lowers Holdings in AbbVie Inc. $ABBV - MarketBeat
60,762 Shares in AbbVie Inc. $ABBV Acquired by North Dakota State Investment Board - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC - MarketBeat
AbbVie stock (US00287Y1091): focus on Humira erosion and Skyrizi growth after latest quarterly repor - AD HOC NEWS
AbbVie Inc stock (US00287Y1091): arthritis drug data and dividend keep the spotlight on the pharma g - AD HOC NEWS
AbbVie Inc. $ABBV Shares Sold by WealthPlan Investment Management LLC - MarketBeat
Soltis Investment Advisors LLC Acquires 12,096 Shares of AbbVie Inc. $ABBV - MarketBeat
L & S Advisors Inc Has $8.01 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Millennium Capital Advisors LLC Purchases New Shares in AbbVie Inc. $ABBV - MarketBeat
Abacus Wealth Partners LLC Boosts Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc stock (US00287Y1091): earnings momentum and pipeline keep big pharma name in focus - AD HOC NEWS
Lawood & Co. Takes Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Lockheed Martin Investment Management Co. - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Convergence Investment Partners LLC Has $4.58 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Commerzbank Aktiengesellschaft FI Sells 10,690 Shares of AbbVie Inc. $ABBV - MarketBeat
DNB Asset Management AS Acquires 81,312 Shares of AbbVie Inc. $ABBV - MarketBeat
Applied Finance Capital Management LLC Has $6.83 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Goldman Sachs Large Cap Growth Insights Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie Inc. stock (US00287Y1091): Pipeline, Humira transition and US market exposure - AD HOC NEWS
ABBV Maintains Rating by Evercore ISI Group -- Price Target Lowe - GuruFocus
Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie? - The Globe and Mail
AbbVie stock (US00287Y1091): earnings beat and dividend keep focus on pipeline - AD HOC NEWS
How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results? - The Globe and Mail
Mubadala Investment Co Pjsc Raises Share Stake In Abbvie, Match Group,Cuts In CVS Health - TradingView
AbbVie Stock Is Up 22% Over the Past Year. Analysts See 37% Upside to $289 Target - TIKR.com
AbbVie FY2027 EPS Forecast Boosted by Erste Group Bank - MarketBeat
We Think You Can Look Beyond AbbVie's (NYSE:ABBV) Lackluster Earnings - simplywall.st
AbbVie's (NYSE:ABBV) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Evercore ISI Adjusts Price Target on AbbVie to $235 From $236, Maintains Outperform Rating - marketscreener.com
AbbVie Inc. $ABBV Shares Purchased by Phoenix Financial Ltd. - MarketBeat
Conning Inc. Has $35.85 Million Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc (ABBV) Stock Price, Trades & News - GuruFocus
2 Reasons to Like ABBV and 1 to Stay Skeptical - TradingView
FDA Approval Gives BeOne Medicines a New Challenger to AbbVie, Roche Cancer Drug - MedCity News
BeiGene Must Face AbbVie's Chemical Trade Secret Claims - Law360
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
Jim Cramer Reveals AbbVie’s (ABBV) “Good Stuff” - Insider Monkey
AbbVie stock (US00287Y1091): Business model and key drivers for US investors - AD HOC NEWS
ABBV Maintained by Piper Sandler -- Price Target Raised to $298 - GuruFocus
Piper Sandler raises Abbvie stock price target on pipeline depth By Investing.com - Investing.com Canada
AbbVie Inc. $ABBV Stock Holdings Lowered by Mesirow Financial Investment Management Inc. - MarketBeat
AbbVie Inc. $ABBV Stock Holdings Decreased by SFE Investment Counsel - MarketBeat
BofA Securities Upgrades AbbVie(ABBV.US) to Buy Rating, Raises Target Price to $234 - Moomoo
17,620 Shares in AbbVie Inc. $ABBV Bought by Rayburn West Financial Services LLC - MarketBeat
Piper Sandler Adjusts Price Target on AbbVie to $298 From $294, Maintains Overweight Rating - Moomoo
Summit Wealth Group LLC Co. Sells 7,049 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie stock (US00287Y1091): Q1 earnings beat and guidance raise drive 3.1% gain - AD HOC NEWS
AbbVie Inc. $ABBV Shares Purchased by Allworth Financial LP - MarketBeat
BeiGene Can’t Toss AbbVie Trade Secrets Suit Over Cancer Therapy - Bloomberg Law News
AbbVie stock (US00287Y1091): Rises 3.3% on 2026 outlook and AGM results - AD HOC NEWS
The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio - Zacks Investment Research
VIRGINIA RETIREMENT SYSTEMS ET Al Has $74.29 Million Position in AbbVie Inc. $ABBV - MarketBeat
Goldman Sachs Large Cap Equity Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
CFO CAPITAL MANAGEMENT LLC's AbbVie Inc(ABBV) Holding History - GuruFocus
A Look At AbbVie (ABBV) Valuation After New Immunology Data And Upgraded 2026 Earnings Outlook - Yahoo Finance
AbbVie Inc. 8-K SEC Filing May 2026: Common Stock and Senior Notes Registered on NYSE - Minichart
AbbVie Inc. (ABBV) Announces Results of 2026 Annual Meeting of S - GuruFocus
AbbVie Shareholders Back Directors, Maintain Governance Structure - TipRanks
AbbVie Inc (ABBV) Stock Up 3.1% and Still Undervalued -- GF Scor - GuruFocus
[Form 4] AbbVie Inc. Insider Trading Activity - Stock Titan
[8-K] AbbVie Inc. Reports Material Event - Stock Titan
Why AbbVie Inc. (ABBV) is One of the Best Healthcare Stocks to Buy for the Long Term - Insider Monkey
AbbVie (ABBV) director Falk awarded 1,118 restricted stock units, holds 2,321 shares - Stock Titan
1.29%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):